Lung Cancer Researcher Diagnosed with Stage 4 Disease Despite Never Smoking: 'I Never Thought I Would Have This'
The oncologist, per the Stanford Medicine blog Scope, was diagnosed with non-small cell cancer — also known as never-smoker ...
Hosted on MSN12d
Lung Cancer Researcher Diagnosed With Stage 4 Disease Even Though He Never Smoked
A researcher at Stanford University School of Medicine has been diagnosed with stage 4 lung cancer, even though he has never ...
WebMD13d
Non-Small-Cell Lung Cancer Treatment by Stage
In stage IB, it’s no more than 4 centimeters and has spread ... into the airway to hold it open. American Cancer Society: “How is non-small cell lung cancer staged?” ...
WebMD8d
FDA Approves Drug for Aggressive Small-Cell Lung Cancer
The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t ...
FDA Grants Breakthrough Therapy Status To Gilead's Trodelvy For Treatment Of Small Cell Lung Cancer
(RTTNews) - Gilead Sciences, Inc. (GILD) Tuesday said that the U.S. Food and Drug Administration or FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adults with ...
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
Monthly Prescribing Reference11d
Imfinzi Approved for Limited-Stage Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...
AOL12d
Lung Cancer Researcher Diagnosed with Stage 4 Disease Despite Never Smoking: 'I Never Thought I Would Have This'
Stanford University School of Medicine clinical professor and researcher Dr. Bryant Lin has been diagnosed with stage ... with non-small cell cancer — also known as never-smoker lung cancer ...
oncnursingnews13d
FDA Approves Durvalumab in Limited-Stage Small Cell Lung Cancer
The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...